La COB et le CMF réglementent la prestation de services financiers en ligne = COB and CMF regulate the prestation of online financial servicesLIPSKIER, M.Expertises des systèmes d'information. 2000, Num 233, pp 432-433, issn 0221-2102Article

Steel against seismic risk: the Italian case = Acier contre les risques sismiques: le cas de l'ItalieDE MARTINO, G.Acier (Ed. française). 1984, Vol 49, Num 4, pp 166-172, issn 0375-832XArticle

ADRIAMYCIN PLUS VINCRISTINE COMPARED TO AND COMBINED WITH CYCLOPHOSPHAMIDE, METHOTREXATE, AND 5-FLUOROURACIL FOR ADVANCED BREAST CANCER = COMPARAISON ET ASSOCIATION DE L'ADRIAMYCINE PLUS VINCRISTINE AU CYCLOPHOSPHAMIDE, METHOTREXATE ET FLUORO-5 URACIL POUR LE CANCER DU SEIN AVANCEDE LENA M; BRAMBILLA C; MORABITO A et al.1975; CANCER; U.S.A.; DA. 1975; VOL. 35; NO 4; PP. 1108-1115; BIBL. 21 REF.Article

Weekly docetaxel versus CMF as adjuvant chemotherapy for elderly breast cancer patients : Safety data from the multicentre phase 3 randomised ELDA trialNUZZO, Francesco; MORABITO, Alessandro; D'AIUTO, Giuseppe et al.Critical reviews in oncology/hematology. 2008, Vol 66, Num 2, pp 171-180, issn 1040-8428, 10 p.Article

METASTATIC ADENOCARCINOMAS OF UNKOWN PRIMARY SITE: A RANDOMIZED STUDY OF TWO COMBINATION-CHEMOTHERAPY REGIMENSWOODS RL; FOX RM; TATTERSALL MHN et al.1980; NEW ENGL. J. MED.; USA; DA. 1980; VOL. 303; NO 2; PP. 87-89; BIBL. 11 REF.Article

Occurrence and behavior of four of the most used sunscreen UV filters in a wastewater reclamation plantWEIHONG LI; YONGMIN MA; CHANGSHENG GUO et al.Water research (Oxford). 2007, Vol 41, Num 15, pp 3506-3512, issn 0043-1354, 7 p.Article

Activite antifongique et screening phytochimique de thos (extrait aqueux de Thonningia sanguinea) = Antifungal activity and phytochemical screening of aqueous extract of Thonningia sanguineaKOUAKOU, A. V; N'GUESSAN, J. D; KRA, A. K. M et al.Journal de la Société ouest-africaine de chimie. 2006, Num 22, pp 21-25, issn 0796-6687, 5 p.Article

ESTROGEN-RECEPTOR STATUS AND RESPONSE TO CHEMOTHERAPY IN EARLY AND ADVANCED BREAST CANCERBONADONNA G; VALAGUSSA P; TANCINI G et al.1980; CANCER CHEMOTHER. PHARMACOL.; DEU; DA. 1980; VOL. 4; NO 1; PP. 37-41; BIBL. 24 REF.Article

CHIMIOTHERAPIE ANI-CANCEREUSE: CONDUITE PRATIQUE ET COORDINATION MEDICALEHOERNI B; DURAND M; CHAUVERGNE J et al.1978; BULL. CANCER; FRA; DA. 1978; VOL. 65; PP. 395-400; ABS. ENG; BIBL. 7 REF.Article

Pothomorphe umbellata: Antifungal activity against strains of Trichophyton rubrumRODRIGUES, E. R; NOGUEIRA, N. G. P; ZOCOLO, G. J et al.Journal de mycologie médicale. 2012, Vol 22, Num 3, pp 265-269, issn 1156-5233, 5 p.Article

Uracil-tegafur and tamoxifen vs cyclophosphamide, methotrexate, fluorouracil, and tamoxifen in post-operative adjuvant therapy for stage I, II, or IIIA lymph node-positive breast cancer: a comparative studySPARK, Y; OKAMURA, K; KOMICHI, H et al.British journal of cancer. 2009, Vol 101, Num 4, pp 598-604, issn 0007-0920, 7 p.Article

CYCLOPHOSPHAMIDE, METHOTREXATE, 5-FLUOROURACIL (CMF) IN ADVANCED GASTROINTESTINAL CANCERSCANNI A; TOMIROTTI M; MARGULIS A et al.1979; TUMORI; ITA; DA. 1979; VOL. 65; NO 1; PP. 111-117; ABS. ITA; BIBL. 10 REF.Article

QUE FAIRE DEVANT UNE TUMEUR DU SEIN OPEREE.GISSELBRECHT C; GORINS A; MARTY M et al.1978; ENTRET. DE BICHAT, THERAPEUT.; FRA; DA. 1978; PP. 17-19; BIBL. 6 REF.Conference Paper

Efficacy of oral tegafur-uracil (UFT) as adjuvant therapy as compared with classical cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in early breast cancer: a pooled analysis of two randomized controlled trials (N·SAS-BC 01 trial and CUBC trial)OHASHI, Yasuo; WATANABE, Toru; SANO, Muneaki et al.Breast cancer research and treatment. 2010, Vol 119, Num 3, pp 633-641, issn 0167-6806, 9 p.Article

Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)PESTALOZZI, B. C; ZAHRIEH, D; SIMONCINI, E et al.Annals of oncology. 2006, Vol 17, Num 6, pp 935-944, issn 0923-7534, 10 p.Article

1-hexylcarbamoyl-5-fluorouracil + cyclophosphamide + tamoxifen versus CMF + tamoxifen in women with lymph node-positive breast cancer after primary surgery : A randomized controlled trialTOMINAGA, Takeshi; KIMURA, Morihiko; AOYAMA, Hideaki et al.Oncology reports. 2004, Vol 12, Num 4, pp 797-803, issn 1021-335X, 7 p.Article

Moderate neutropenia with adjuvant CMF confers improved survival in early breast cancerCAMERON, D. A; MASSIE, C; KERR, G et al.British journal of cancer. 2003, Vol 89, Num 10, pp 1837-1842, issn 0007-0920, 6 p.Article

Survival analyses from the ZEBRA study: goserelin (Zoladex) versus CMF in premenopausal women with node-positive breast cancerKAUFMANN, M; JONAT, W; BLAMEY, R et al.European journal of cancer (1990). 2003, Vol 39, Num 12, pp 1711-1717, issn 0959-8049, 7 p.Article

CHIMIOTHERAPIE DES CANCERS DU SEIN EVOLUES. ANALYSE PRELIMINAIRE D'UN ESSAI THERAPEUTIQUE CONTROLE PORTANT SUR 100 MALADESMARTRON JEAN LOUIS.1979; ; FRA; BORDEAUX: AMICALE CORP. ETUD. MED.; DA. 1979; 148; 52 P.: ILL.; 23 CM; BIBL. 16 REF.; TH.: MED./BORDEAUX 2/1979Thesis

Same gain, less pain: potential patient preferences for adjuvant treatment in premenopausal women with early breast cancerFALLOWFIELD, Lesley; MCGURK, Rhona; DIXON, Michael et al.European journal of cancer (1990). 2004, Vol 40, Num 16, pp 2403-2410, issn 0959-8049, 8 p.Article

LOW DOSE CHEMOTHERAPY OF METASTATIC BREAST CANCER WITH CYCLOPHOSPHAMIDE, ADRIAMYCIN, METHOTREXATE, 5-FLUOROURACIL (CAMF) VERSUS SEQUENTIAL CYCLOPHOSPHAMIDE, METHOTREXATE, 5-FLUOROURACIL (CMF) AND ADRIAMYCINCREECH RH; CATALANO RB; HARRIS DT et al.1979; CANCER; USA; DA. 1979; VOL. 43; NO 1; PP. 51-59; BIBL. 11 REF.Article

ADJUVANTE CHEMOTHERAPIE DES MAMMA-CA = CHIMIOTHERAPIE COMME TRAITEMENT ADJUVANT DU CANCER DU SEINFIRUSIAN N; HOSSFELD DK; JOHN V et al.1978; ROENTG.-BL.; DEU; DA. 1978; VOL. 31; NO 7; PP. 423-428; ABS. ENG; BIBL. 15 REF.Article

ADJUVANT CHEMOTHERAPY FOR OPERABLE BREAST CANCER WITH POSITIVE AXILLARY NODES. AN INTERIM VIEW OF STILL PRELIMINARY DATA.CARTER SK.1977; CANCER IMMUNOL. IMMUNOTHERAPY; GERM.; DA. 1977; VOL. 2; NO 3; PP. 147-150; BIBL. 22 REF.Article

ADJUVANT COMBINATION CHEMOTHERAPY WITH CMF IN PRIMARY MAMMARY CARCINOMA.VERONESI U; ROSSI A; BONADONNA G et al.1977; WORLD J. SURG.; GERM.; DA. 1977; VOL. 1; NO 3; PP. 337-340; ABS. FR.Article

AN EFFECTIVE LOW-DOSE INTERMITTENT CYCLOPHOSPHAMIDE, METHOTREXATE, AND 5-FLUOROURACIL TREATMENT REGIMEN FOR METASTATIC BREAST CANCER = UN SCHEMA DE TRAITEMENT INTERMITTENT A FAIBLES DOSES EFFICACE PAR LE CYCLOPHOSPHAMIDE, METHOTREXATE ET FLUORO-5 URACIL POUR LE CANCER DU SEIN METASTATIQUECREECH RH; CATALANO RB; MASTRANGELO MJ et al.1975; CANCER; U.S.A.; DA. 1975; VOL. 35; NO 4; PP. 1101-1107; BIBL. 12 REF.Article